Page 4 - மருந்து ஆம்ப் சாதனம் வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ஆம்ப் சாதனம் வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ஆம்ப் சாதனம் வளர்ச்சி Today - Breaking & Trending Today

Swiss gov't looks to boost domestic COVID-19 vaccine, therapy production

By Reuters Staff
2 Min Read
FILE PHOTO: People wait in the registration area at the Impfzentrum Basel Stadt vaccination center at the Congress Center of the Messe Basel fairground, as the spread of the coronavirus disease (COVID-19) continues, in Basel, Switzerland March 18, 2021. REUTERS/Arnd Wiegmann
ZURICH (Reuters) -Switzerland will investigate ways to strengthen domestic COVID-19 vaccine and drug development and production, the government said on Wednesday, reacting as global demand outstrips supply due to rising infections at home and abroad.
The government also announced it was setting aside $100 million to buy costly antibody therapies, including from U.S.-based Regeneron and Swiss drugmaker Roche, in part for those who are still unvaccinated but live in households where somebody has been infected. ....

Brenna Hughes Neghaiwi , John Miller , Alain Berset , Thomson Reuters Trust Principles , Swiss Health , Health Minister Alain Berset , Brenna Hughes , Thomson Reuters Trust , Corona Virus , Drug Amp Device Development , Government Finances , Health Medicine , Pharmaceuticals Trbc Level 4 , Pharmaceuticals Nec Trbc Level 5 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Western Europe , ஜான் மில்லர் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , சுவிஸ் ஆரோக்கியம் , ப்ரென்னா ஹக்ஸ் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை , கொரோனா வைரஸ் , மருந்து ஆம்ப் சாதனம் வளர்ச்சி , அரசு நிதி , ஆரோக்கியம் மருந்து , தடுப்பு மருந்துகள் ,

EU drug regulator to issue view on J&J vaccine next week

By Reuters Staff
2 Min Read
FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) -Europe’s drug regulator said on Wednesday it planned to issue a recommendation on Johnson & Johnson’s COVID-19 vaccine next week, but that it continued to believe the benefits of the shot outweighed the risks of side effects.
The European Medicines Agency (EMA) is reviewing a small number of cases in the United States of very rare blood clotting disorders among people who had received the J&J vaccine. ....

United States , Ludwig Burger , Mark Potter , Yadarisa Shabong , Aditya Soni , Thomson Reuters Trust Principles , European Medicines Agency , European Union On , European Union , Thomson Reuters Trust , Corona Virus , Content Produced In Bangalore , Company News , Drug Amp Device Development , United Kingdom , Healthcare Trbc Level 1 , Medical Regulation , Major News , Pharmaceuticals Nec Trbc Level 5 , Corporate Market Regulation , Reuters Top News , ஒன்றுபட்டது மாநிலங்களில் , லுட்விக் பர்கர் , குறி பாடர் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , ஐரோப்பிய தொழிற்சங்கம் ஆன் ,

China's mRNA COVID-19 vaccine may start late-stage trial in May - state media

By Reuters Staff
2 Min Read
FILE PHOTO: A woman holds a small bottle labeled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in front of displayed China flag in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic
BEIJING (Reuters) - China’s locally developed COVID-19 vaccine candidate that uses messenger RNA (mRNA) technology could start late-stage clinical trial overseas as early as next month, official media said on Tuesday.
ARCoV, the China-developed mRNA vaccine candidate that is furthest along the clinical trial process, may get overseas approval to conduct Phase III clinical trial by as early as end-April, China National Radio said in an article on its website. ....

United States , Abogen Biosciences , Roxanne Liu , Miyoung Kim , Ying Bo , Rhodiola Pharma , Qin Chengfeng , Thomson Reuters Trust Principles , Pfizer Inc , Moderna Inc , Academy Of Military Sciences , China National Radio , Military Science , Suzhou Abogen Biosciences , South America , Suzhou Abogen , Stemirna Therapeutics , Tibet Rhodiola Pharma , Ryan Woo , Ana Nicolaci , Thomson Reuters Trust , Corona Virus , Asia Pacific , Company News , China Prc , Drug Amp Device Development ,

Explainer: How worried should we be about blood clots linked to AstraZeneca and J&J vaccines?

7 Min Read
ZURICH (Reuters) - U.S. regulators have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine as they investigate rare blood clotting in six women, including one who died.
Syringes are prepared to administer the AstraZeneca coronavirus disease (COVID-19) vaccine at a new mass vaccination centre in WiZink sports arena in Madrid, Spain, April 9, 2021. REUTERS/Sergio Perez
J&J also said it was delaying the rollout of its vaccine in Europe. U.S. officials said the temporary halt is expected only to last a few days.
The move comes after Europe’s drug regulator said it had found a possible link between AstraZeneca’s COVID-19 vaccine and very rare blood clots in some adults who had received the shot. ....

United Kingdom , United States , France General , Mecklenburg Vorpommern , City Of , Ludwig Burger , Julie Steenhuysen , Josephine Mason , Angus Macswan , Matthias Blamont , Andreas Greinacher , Alistair Smout , Susan Fenton , John Miller , Kate Kelland , Thomson Reuters Trust Principles , Greifswald University , Drug Administration , A Us Centers For Disease , University Of Cambridge Winton Centre For Risk , Regulatory Agency , European Medicines Agency , Disease Control , European Economic Area , Winton Centre , Evidence Communication ,

France to prioritise overseas territories for J&J COVID-19 vaccine

France is likely to prioritise citizens based in its overseas territories and those with low income for the single-dose COVID-19 vaccine made by Johnson & Johnson, an official with the health ministry said on Tuesday. ....

France General , Matthias Blamont , Raissa Kasolowsky , Thomson Reuters Trust Principles , European Union , President Emmanuel Macron , Thomson Reuters Trust , Corona Virus , Diplomacy Foreign Policy , Drug Amp Device Development , General News , Health Medicine , Healthcare Trbc Level 1 , Biotechnology Amp Medical Research Trbc Level 4 , Major News , Respiratory Conditions , Western Europe , பிரான்ஸ் ஜநரல் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , ஐரோப்பிய தொழிற்சங்கம் , ப்ரெஸிடெஂட் இம்மானுவேல் மேக்ரான் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை , கொரோனா வைரஸ் , இராஜதந்திரம் வெளிநாட்டு பாலிஸீ , மருந்து ஆம்ப் சாதனம் வளர்ச்சி , ஜநரல் செய்தி ,